(-)-Denudatin B;C10554;(2S,3R,3aS)-2-(3,4-dimethoxyphenyl)-3a-methoxy-3-methyl-5-prop-2-enyl-2,3-dihydrobenzofuran-6-one;6(2H)-Benzofuranone, 2-(3,4-dimethoxyphenyl)-3,3a-dihydro-3a-methoxy-3-methyl-5-(2-propen-1-yl)-, (2S,3R,3aR)-;Acetylcholine-d;(-)-DenudatinB;Denudatin B
(-)-Denudatin B exhibits antiplatelet activity by inhibiting Ca²⁺ influx through voltage-gated and receptor-operated Ca²⁺ channels, leading to relaxation of vascular smooth muscle; it also demonstrates non-specific antiplatelet effects at high concentrations by inhibiting collagen- and thrombin-induced phosphoinositide breakdown.